Original from: fiercebiotech

Roche has named the next CEO for its diagnostics efforts, as its prior division chief, Thomas Schinecker, is waiting in the wings to head up the Big Pharma overall starting next March. 

Matt Sause is slated to step in as CEO beginning January 1, 2023. Currently head of Roche Diagnostics’ North America region, Sause’s career at the company has spanned about two decades, with shorter stints working for Genentech and Gilead Sciences in between.

He first started at Roche in 2002 as a U.S. senior molecular account manager, before taking on diagnostics and pharma positions in countries including Japan, Ireland, Peru and South Korea. In 2018, he joined Roche’s Genentech to help shepherd Tecentriq's development in lung and head and neck cancers.

Source: Roche Diagnostics taps North American head Sause to be next CEO